Caraco Pharmaceutical Labs (CPD) Posts Q3 EPS of $0.17
More News related to CPD
- Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection
- Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
- Caraco Pharmaceutical Labs (CPD) Posts Q3 EPS of $0.17
- Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
- Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
Caraco Pharmaceutical Laboratories Ltd. (AMEX: CPD) reports Q2 EPS of $0.17, versus the analyst estimate of ($0.17). Revenue for the quarter was $78.38 million, which compares to the estimate of $45.84 million.
Related Categories
EarningsStocks Mentioned
+0.08Comments
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
Layoffs at Caraco
Cindy Wiegand on Oct 27, 2009 10:02 AMWhy hasnt Caraco announced their layoffs of dozens of people a few weeks ago? That was the second set of layoffs since June of this year????